Nutrition-oriented, non-pharmacologic therapies to reduce blood pressure (BP) are receiving considerable attention as safe, and potentially effective, modalities to treat and prevent hypertension (HTN). Of the numerous dietary factors known to influence BP, evidence is most convincing for sodium, alcohol and weight. While potentially effective, the influence of calcium, magnesium and potassium intakes and of diets modified in macronutrient intake (high/low protein, saturated fat, polyunsaturated fat, carbohydrate and fiber) is less persuasive. The goal of the proposed research effort is to elucidate the BP-lowering effect of dietary patterns which combine these promising, but incompletely evaluated, dietary factors. Based on our review of available evidence, diets modified in macronutrient and/or micronutrient intake appear most promising. The proposed study will be a multi-center feeding study in which eligible participants are randomized to one of four diets (typical, modified macronutrient, modified micronutrient, or combined modified macronutrient/modified micronutrient diet). The modified macronutrient diet will provide foods comparatively high in protein, low in saturated fat and high in omega-3 polyunsaturated fatty acids, while the modified micronutrient diet will provide a diet comparatively high in calcium, magnesium and potassium. The study population (55% Afro-American) will consist of men and women (ages 25-54) with a mean baseline diastolic B.P of 85-94 mmHg. The initial 12 months will be devoted to protocol development and will include a pilot of the proposed diets. During the next two years, 480 individuals, 120 at each of four clinical centers, will be randomly assigned to one of the above four dietary patterns. The duration of the intervention period will be three months. Substantial efforts will be devoted to monitoring and enhancing adherence to the assigned diets. The principal trial endpoint will be the net change in diastolic BP.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL050981-03
Application #
2227323
Study Section
Special Emphasis Panel (ZHL1-CCT-M (M1))
Project Start
1993-08-01
Project End
1997-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Hikmat, Fadi; Appel, L J (2014) Effects of the DASH diet on blood pressure in patients with and without metabolic syndrome: results from the DASH trial. J Hum Hypertens 28:170-5
Chen, Q; Turban, S; Miller, E R et al. (2012) The effects of dietary patterns on plasma renin activity: results from the Dietary Approaches to Stop Hypertension trial. J Hum Hypertens 26:664-9
Chen, Steven T; Maruthur, Nisa M; Appel, Lawrence J (2010) The effect of dietary patterns on estimated coronary heart disease risk: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Circ Cardiovasc Qual Outcomes 3:484-9
Anderson, Cheryl A M; Jee, Sun Ha; Charleston, Jeanne et al. (2010) Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. Am J Epidemiol 172:932-41
Vollmer, W M; Appel, L J; Svetkey, L P et al. (2005) Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens 19:77-82
Lin, Pao-Hwa; Proschan, Michael A; Bray, George A et al. (2003) Estimation of energy requirements in a controlled feeding trial. Am J Clin Nutr 77:639-45
Craddick, Shirley R; Elmer, Patricia J; Obarzanek, Eva et al. (2003) The DASH diet and blood pressure. Curr Atheroscler Rep 5:484-91
Lin, Pao-Hwa; Ginty, Fiona; Appel, Lawrence J et al. (2003) The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. J Nutr 133:3130-6
Erlinger, Thomas P; Vollmer, William M; Svetkey, Laura P et al. (2003) The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives. Prev Med 37:327-33
Svetkey, L P; Moore, T J; Simons-Morton, D G et al. (2001) Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 19:1949-56

Showing the most recent 10 out of 17 publications